Cholemax

Cholemax Special Precautions

ursodeoxycholic acid

Manufacturer:

MacroPhar

Distributor:

MacroPhar Lab
Full Prescribing Info
Special Precautions
Ursodeoxycholic acid has not been associated with the liver damage; however, measure AST and ALT at initiation of and during therapy as indicated by particular clinical circumstances.
Monitoring: perform ultrasound images of gall bladder at 6-month intervals for first year of therapy to monitor gallstone response. If partial stone dissolution is not seen by 12 months of therapy, likelihood of success is greatly reduced.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in